CD (Suzhou) Biopharma Co., Ltd.

Media

CD (Suzhou) Biopharma Announces FDA Clearance for ... CD (Suzhou) Biopharma Announces FDA Clearance for ... CD (Suzhou) Biopharma Announces FDA Clearance for ...

2024-09-20 15:24:31

Suzhou, China – September 20, 2024 – CD (Suzhou) Biopharma has received clearance from the U.S.....

Suzhou, China – September 20, 2024 – CD (Suzhou) Biopharma has received clearance from the U.S.....

Suzhou, China – September 20, 2024 –...
CD BioPharma presented at the 2024 AACR conference... CD BioPharma presented at the 2024 AACR conference... CD BioPharma presented at the 2024 AACR conference...

2024-04-16 13:23:23

We demonstrated a breakthrough in preclinical research of CAR-T (PD-1Ab21-CAR-T) cells secreting a f...

We demonstrated a breakthrough in preclinical research of CAR-T (PD-1Ab21-CAR-T) cells secreting a f...

We demonstrated a breakthrough in pr...
CD BioPharma won the first place “Outstanding Inno... CD BioPharma won the first place “Outstanding Inno... CD BioPharma won the first place “Outstanding Inno...

2024-01-24 15:52:03

Driven by independent innovation, through the technical platform of efficient and safe antibody-cyto...

Driven by independent innovation, through the technical platform of efficient and safe antibody-cyto...

Driven by independent innovation, th...
CD Biopharma – New Armored CAR-T has achieved good... CD Biopharma – New Armored CAR-T has achieved good... CD Biopharma – New Armored CAR-T has achieved good...

2023-03-07 17:00:13

Commercial CAR-T treatment often exceeds one million at a time, and the curative effect is not satis...

Commercial CAR-T treatment often exceeds one million at a time, and the curative effect is not satis...

Commercial CAR-T treatment often exc...

Contact Us

Address: Room 610, North Building, No. 689 Binhe Road, Huqiu District, Suzhou City
Tel: 086-512-68765766
Email: cd@cdbiopharma.com

Follow us

Copyright © 2021-2024 CD (Suzhou) Biopharma Co., Ltd. All rights reserved.